Pune: Startup India, Invest India and Department of Pharmaceuticals at NIPER Hyderabad and NIPER Ahmedabad in collaboration with Laurus Labs and Boston Scientific are jointly hosting the ‘Pharma and Medical Devices Startup Grand Challenge’, an unique opportunity for startups in the pharmaceuticals and medical devices sector.

Click here to apply for the Pharma, Medical Devices Startup Grand Challenge

The last date for applying for this contest is April 10, 2021 while the results will be announced on April 15, 2021.

Benefits of applying to the program:

  • Cash grants worth INR 44 Lakhs
  • Demo Day in front of the leadership from Laurus Labs & Boston Scientific
  • Mentorship from experts from Corporates, NIPER Hyderabad, & NIPER Ahmedabad
  • Platform to connect with mentors who can help you scale and to showcase your product
  • Opportunity to pitch to investors at Demo Day

Problem Statement

Pharma: Build solutions for the pharmaceuticals sector in India

Indian pharmaceutical sector is expected to grow to US$ 130 billion by 2025. Startups will contribute significantly in achieving this goal. If you have a product or a service that solves for a problem, creates high impact or/and builds in efficiency and effectiveness in an existing unique, innovative solution, then apply now for the challenge!

Medical Devices: Build solutions for the medical devices sector in India

If you have a product that creates high impact or/and builds in efficiency and effectiveness in an existing unique, innovative solution, then apply now for the challenge!

Also Read: MediAsha Co-founder Komal Sanas selected for Asia’s 1000 Women Awards

Eligibility Criteria

Pharmaceuticals

  • The challenge is open to Indian Startups
  • All applicants should have market ready product

Medical Devices

  • The challenge is open to Indian Startups
  • All applicants should have a prototype ready for commercialisation before applying for the Challenge
  • Preference to startups that have Innovative solutions in areas where India is not self reliant at the moment
  • Aggregator Platforms will not be considered

About the author

TEAMIU

Leave a Comment